Una Ørvim Sølvik

708 total citations
32 papers, 516 citations indexed

About

Una Ørvim Sølvik is a scholar working on Physiology, Statistics, Probability and Uncertainty and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Una Ørvim Sølvik has authored 32 papers receiving a total of 516 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Physiology, 11 papers in Statistics, Probability and Uncertainty and 10 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Una Ørvim Sølvik's work include Clinical Laboratory Practices and Quality Control (13 papers), Diabetes Management and Research (7 papers) and Meta-analysis and systematic reviews (6 papers). Una Ørvim Sølvik is often cited by papers focused on Clinical Laboratory Practices and Quality Control (13 papers), Diabetes Management and Research (7 papers) and Meta-analysis and systematic reviews (6 papers). Una Ørvim Sølvik collaborates with scholars based in Norway, United Kingdom and Spain. Una Ørvim Sølvik's co-authors include Sverre Sandberg, Thomas Røraas, Anne Stavelin, Reidun Lisbet Skeide Kjome, Marit Sverresdotter Sylte, Pilar Fernández–Calle, Anna Carobene, William A. Bartlett, Niels Jonker and Jorge Díaz–Garzón and has published in prestigious journals such as PLoS ONE, Clinical Chemistry and Thrombosis and Haemostasis.

In The Last Decade

Una Ørvim Sølvik

30 papers receiving 489 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Una Ørvim Sølvik Norway 11 250 128 122 99 82 32 516
Carmen Biosca Spain 12 444 1.8× 270 2.1× 37 0.3× 93 0.9× 111 1.4× 33 633
Janice Gill Australia 13 231 0.9× 150 1.2× 76 0.6× 49 0.5× 38 0.5× 20 442
Virtudes Álvarez Spain 16 571 2.3× 330 2.6× 68 0.6× 127 1.3× 155 1.9× 30 859
Joana Minchinela Spain 16 621 2.5× 337 2.6× 86 0.7× 147 1.5× 189 2.3× 34 996
Farhad Arzideh Germany 13 406 1.6× 235 1.8× 76 0.6× 166 1.7× 151 1.8× 25 691
Gunn B.B. Kristensen Denmark 11 385 1.5× 225 1.8× 27 0.2× 76 0.8× 28 0.3× 13 500
Zorica Šumarac Serbia 13 506 2.0× 266 2.1× 14 0.1× 98 1.0× 35 0.4× 30 705
A. Uldall Denmark 11 261 1.0× 136 1.1× 60 0.5× 96 1.0× 48 0.6× 54 622
Michael Metz Australia 14 139 0.6× 72 0.6× 35 0.3× 139 1.4× 29 0.4× 38 500
Dianne Kitchen United Kingdom 18 114 0.5× 60 0.5× 11 0.1× 109 1.1× 17 0.2× 31 741

Countries citing papers authored by Una Ørvim Sølvik

Since Specialization
Citations

This map shows the geographic impact of Una Ørvim Sølvik's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Una Ørvim Sølvik with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Una Ørvim Sølvik more than expected).

Fields of papers citing papers by Una Ørvim Sølvik

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Una Ørvim Sølvik. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Una Ørvim Sølvik. The network helps show where Una Ørvim Sølvik may publish in the future.

Co-authorship network of co-authors of Una Ørvim Sølvik

This figure shows the co-authorship network connecting the top 25 collaborators of Una Ørvim Sølvik. A scholar is included among the top collaborators of Una Ørvim Sølvik based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Una Ørvim Sølvik. Una Ørvim Sølvik is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sølvik, Una Ørvim, et al.. (2025). Self-management of INR – a focus group study. Tidsskrift for Den norske legeforening. 145(6).
3.
Kjome, Reidun Lisbet Skeide, et al.. (2023). Diabetes risk assessments and HbA1c-measurements in community pharmacies. International Journal of Pharmacy Practice. 31(5). 512–519. 4 indexed citations
5.
Cooper, John G., Siri Carlsen, Jannicke Igland, et al.. (2023). Intensified follow-up of patients with type 1 diabetes and poor glycaemic control: a multicentre quality improvement collaborative based on data from the Norwegian Diabetes Register for Adults. BMJ Open Quality. 12(2). e002099–e002099. 1 indexed citations
6.
Kjome, Reidun Lisbet Skeide, et al.. (2020). Pharmacists’ experience of a diabetes risk-assessment service and analytical quality control in community pharmacies – A focus-group study. Research in Social and Administrative Pharmacy. 17(7). 1259–1266. 5 indexed citations
7.
8.
Sølvik, Una Ørvim, et al.. (2019). Quality of Warfarin Therapy and Quality of Life are Improved by Self-Management for Two Years. Thrombosis and Haemostasis. 119(10). 1632–1641. 8 indexed citations
9.
Sølvik, Una Ørvim, et al.. (2018). Quality Control of Norwegian Pharmacy HbA1c Testing: A Modest Beginning. Journal of Diabetes Science and Technology. 12(4). 753–761. 4 indexed citations
10.
Kjome, Reidun Lisbet Skeide, et al.. (2018). Risk assessment and HbA1c measurement in Norwegian community pharmacies to identify people with undiagnosed type 2 diabetes – A feasibility study. PLoS ONE. 13(2). e0191316–e0191316. 6 indexed citations
11.
Sølvik, Una Ørvim, et al.. (2017). Intensive educational efforts combined with external quality assessment improve the preanalytical phase in general practitioner offices and nursing homes. Clinical Chemistry and Laboratory Medicine (CCLM). 55(12). 1857–1864. 6 indexed citations
12.
Granås, Anne Gerd, et al.. (2016). ‘I try not to bother the residents too much’ – the use of capillary blood glucose measurements in nursing homes. BMC Nursing. 15(1). 7–7. 1 indexed citations
14.
Sølvik, Una Ørvim, et al.. (2015). Egenkontroll av warfarinbehandling. Tidsskrift for Den norske legeforening. 135(9). 849–853. 5 indexed citations
15.
Sølvik, Una Ørvim, et al.. (2014). The influence of coagulation factors on thein-treatmentbiological variation of international normalized ratio for patients on warfarin. Scandinavian Journal of Clinical and Laboratory Investigation. 74(6). 470–476. 8 indexed citations
16.
Sandberg, Sverre, et al.. (2014). Nursing home patients with diabetes: Prevalence, drug treatment and glycemic control. Diabetes Research and Clinical Practice. 105(1). 102–109. 36 indexed citations
17.
Sølvik, Una Ørvim, et al.. (2012). Effect of coagulation factors on discrepancies in International Normalized Ratio results between instruments. Clinical Chemistry and Laboratory Medicine (CCLM). 50(9). 1611–20. 9 indexed citations
18.
Sølvik, Una Ørvim, et al.. (2010). Discrepancies in International Normalized Ratio Results between Instruments: A Model to Split the Variation into Subcomponents. Clinical Chemistry. 56(10). 1618–1626. 14 indexed citations
19.
Sølvik, Una Ørvim, et al.. (2006). External quality assessment of prothrombin time: The split‐sample model compared with external quality assessment with commercial control material. Scandinavian Journal of Clinical and Laboratory Investigation. 66(4). 337–350. 14 indexed citations
20.
Sølvik, Una Ørvim, et al.. (2001). C1-inhibitor attenuates human serum induced E-selectin expression of pig aortic endothelial cells. Transplantation Proceedings. 33(1-2). 789–790. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026